Margita Držaić

Margita Držaić

Auto-generated profile, based on publicly available information

Margita Držaić

Centre for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IBIva Bužančić
Iva Bužančić
MDMargita Držaić
Margita Držaić
IKIngrid Kummer
Ingrid Kummer
MHMaja Ortner Hadžiabdić
Maja Ortner Hadžiabdić
JBJovana Brkić
Jovana Brkić
DFDaniela Fialová
Daniela Fialová
Pharmacist’s geriatric assessment can provide valuable insights into potential deprescribing targets, while including important information on various health-related domains. Data collected from a geriatric assessment questionnaire, for 388 patients, from the Croatian cohort of the EuroAgeism H2020 ESR 7 international project, along with guideline-based deprescribing criteria, were used to analyse potentially inappropriate prescribing of four medication groups (benzodiazepines (BZN), proton pump inhibitors (PPI), opioids, and non-steroidal anti-inflammatory drugs (NSAID)), and to assess the deprescribing potential. Binary logistic regression was used to explore the effects of age, gender, number of medicines and diagnoses, self-reported health, frailty score, and healthcare utilization on the likelihood of needing deprescribing. More than half of participants (n = 216, 55.2%) are candidates for deprescribing, with 31.1% of PPI, 74.8% of NSAID, 75% of opioid, and 96.1% of BZN users meeting at least one criterion. Most common criteria for deprescribing were inappropriately long use and safety concerns. Women (aOR = 2.58; p < 0.001), those reporting poor self-reported health (aOR = 5.14; p < 0.001), and those exposed to polypharmacy (aOR = 1.29; p < 0.001) had higher odds of needing to have medicines deprescribed. The high rate of deprescribing potential warrants prompt action to increase patient safety and decrease polypharmacy. Pharmacist’s geriatric assessment and deprescribing-focused medication review could be used to lead a personalised approach.

1 December 2024 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
EPElizabeta Paar
Elizabeta Paar
ELEleonora De Lai
Eleonora De Lai
MDMargita Držaić
Margita Držaić
IKIngrid Kummer
Ingrid Kummer
IBIva Bužančić
Iva Bužančić
DFDaniela Fialová
Daniela Fialová
Our study aimed to assess the prevalence of fall risk-increasing drugs (FRIDs) in a sample of community-residing older patients in Croatia and its association with negative health outcomes. An observational, cross-sectional study was conducted on older patients (65+) visiting community pharmacies in three regionally different study sites in Croatia. Data were collected using a questionnaire developed for that purpose and included components of comprehensive geriatric assessment. Prevalence of FRIDs was identified using the “Screening Tool of Older Persons Prescriptions in older adults with high fall risk” (STOPPFall). In the sample of 407 participants (median age 73 (IQR 69–70) years; 63.9 % females), 79.1 % used at least one FRID. The most common drug classes were diuretics, benzodiazepines, and opioids (in 51.1 %, 38.1 %, and 17.2 % participants, respectively). More FRIDs were prescribed to the oldest old patients (85+) and participants from poorer regions of Croatia (Slavonia) ( p < 0.05). Exposition to FRIDs was identified as the significant risk factor associated with falls (OR = 1.24 (1.04–1.50); p = 0.020) and higher health-care utilization (OR = 1.29 (1.10–1.51); p = 0.001). Our study highlights the need for rationalization of FRID use. To reduce the unnecessary exposure to FRIDs in older adults, health-care professionals must consider high individualization of medication schemes regarding selection, dosing, and combinations of only necessary FRIDs.

22 April 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IBIva Bužančić
Iva Bužančić
MDMargita Držaić
Margita Držaić
IKIngrid Kummer
Ingrid Kummer
MHMaja Ortner Hadžiabdić
Maja Ortner Hadžiabdić
JBJovana Brkić
Jovana Brkić
DFDaniela Fialová
Daniela Fialová

4 November 2025 in Annals of Medicine
Verified
Journal Article
Open access
JBJovana Brkic
Jovana Brkic
JRJindra Reissigova
Jindra Reissigova
BOBetul Okuyan
Betul Okuyan
MHMaja Ortner Hadžiabdić
Maja Ortner Hadžiabdić
VMValentina Marinkovic
Valentina Marinkovic
DFDaniela Fialová
Daniela Fialová
The aim of this study was to examine the prevalence of potentially inappropriate medication (PIM) use and its associated risk factors in community-dwelling older adults from five Central and Eastern European (CEE) countries. This secondary analysis of a cross-sectional survey, which was part of the Horizon 2020 EuroAgeism ESR7 project, was conducted between February 2019 and March 2020 in Bulgaria, Croatia, Czechia, Estonia, and Serbia. We enrolled older adults aged ≥65 years who visited community pharmacies to acquire medications. The prevalence of PIM use was determined by applying all 282 criteria from the EU(7)-PIM list. Risk and protective factors for PIM use were evaluated using multiple logistic regression. R software version 4.3.2 was used in statistical analysis. Most of the 2,155 participants were women (63.3%) and aged 65-74 years (64.8%). The overall PIM prevalence was 56.0% (95% confidence interval 53.8%-58.1%), ranging from 29.5% in Czechia to 70.0% in Croatia. The most commonly used PIMs were benzodiazepines (16.7% of all PIMs), followed by nonsteroidal anti-inflammatory drugs (14.3%), and proton pump inhibitors taken for more than 8 weeks (14.1%). Multiple logistic regression revealed that residence, increasing comorbidity burden, and polypharmacy were significant risk factors associated with PIM use in older adults. Our findings demonstrate a high prevalence of PIM use among older patients from CEE countries and considerable cross-country differences, underscoring the need to improve medication prescribing for older adults to improve healthcare quality and patient outcomes.